Efficacy analysis and prognostic factors of first-line chemotherapy combined with immunotherapy in extensive-stage small cell lung cancer: a real-world study

Efficacy analysis and prognostic factors of first-line chemotherapy combined with immunotherapy in extensive-stage small cell lung cancer: a real-world study

Abstract Extensive-stage small cell lung cancer (ES-SCLC) is a highly aggressive subtype of lung cancer with limited treatment options and poor prognosis. In recent years, immune checkpoint inhibitors (ICIs) combined with chemotherapy have demonstrated significant efficacy in several clinical trials...

Full description

Saved in:
Bibliographic Details
Main Authors: Jian-Xi Zhou, Yun-Chuan Sun, Li Xiao, Hong-Ling Lu, Xiao-Ming Yin, Kui Fan, Ying-Nan Zhou
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-98018-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items